LivaNova (LIVN) Total Current Liabilities (2015 - 2026)
LivaNova's (LIVN) quarterly Total Current Liabilities came in at $707.0 million in Q2 2026, down 14.52% year-over-year from $827.1 million in Q2 2025, and down 7.28% quarter-over-quarter from $762.5 million in Q1 2026.
Analysis
LivaNova (LIVN) Total Current Liabilities (2015 - 2026) Analysis & Trends
LivaNova has disclosed Total Current Liabilities across 12 years of filings, most recently posting $707.0 million for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 14.52% year-over-year to $707.0 million; the TTM figure through Jun 2026 stood at $707.0 million (down 14.52% YoY), while the FY2025 annual figure was $808.1 million, up 106.08% from the prior year.
- Total Current Liabilities came in at $707.0 million for Q2 2026 at LivaNova, down from $762.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $827.6 million in Q3 2025 to a low of $263.9 million in Q2 2022.
- Average Total Current Liabilities over 5 years is $467.4 million, with a median of $326.1 million recorded in 2024.
- Year-over-year, Total Current Liabilities sank 62.42% in 2022 and surged 172.98% in 2025.
- Over 5 years, Total Current Liabilities stood at $297.4 million in 2022, then increased by 12.64% to $335.0 million in 2023, then gained by 17.06% to $392.1 million in 2024, then soared by 106.08% to $808.1 million in 2025, then retreated by 12.51% to $707.0 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $707.0 million in Q2 2026, $762.5 million in Q1 2026, and $808.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 1.28 Bn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 707.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 707.00 Mn |
| Mar 31, 2026 | 762.48 Mn |
| Dec 31, 2025 | 808.07 Mn |
| Sep 30, 2025 | 827.59 Mn |
| Jun 30, 2025 | 827.10 Mn |
| Mar 31, 2025 | 741.57 Mn |
| Dec 31, 2024 | 392.13 Mn |
| Sep 30, 2024 | 324.40 Mn |
| Jun 30, 2024 | 302.99 Mn |
| Mar 31, 2024 | 327.77 Mn |
| Dec 31, 2023 | 334.98 Mn |
| Sep 30, 2023 | 295.40 Mn |
| Jun 30, 2023 | 288.16 Mn |
| Mar 31, 2023 | 316.13 Mn |
| Dec 31, 2022 | 297.40 Mn |
| Sep 30, 2022 | 288.02 Mn |
| Jun 30, 2022 | 263.89 Mn |
| Mar 31, 2022 | 307.91 Mn |
| Dec 31, 2021 | 696.97 Mn |
| Sep 30, 2021 | 658.47 Mn |